<?xml version="1.0" encoding="UTF-8"?>
<p id="Par45">ATOMIC2 was registered with ClinicalTrials.gov NCT04381962 on 11 May 2020, EudraCT identifier 2020-001740-26, and opened for accrual on 29 May 2020.</p>
